Our research on antibody-dependent enhancement of infection using cMylc cells has been published in “Scientific Reports”.

We have conducted a joint research project using immortalized myeloid lineage cells 【cMylc (coronavirus optimized myeloid lineage) cells】generated from iPS cells for research on novel coronavirus (SARS-CoV-2) with the Research Institute for Microbial Diseases, Osaka University. The study on antibody-dependent enhancement of infection (ADE) using cMylc cells, anti-SARS-CoV-2 therapeutic antibodies and sera after mRNA-vaccination has been published in the British online scientific journal Scientific Reports on September 16, 2022 (Japan Standard Time).

READ MORE（PDF）→